{"id":"sodium-phosphate-32p","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"V10XX01","category":"atc"},{"label":"Active","category":"status"},{"label":"Polycythemia vera","category":"indication"},{"label":"Mallinckrodt","category":"company"},{"label":"Approved 1950s","category":"decade"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"company":"Mallinckrodt","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=sodium phosphate (32P)","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:04:17.345424+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:04:22.831790+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=sodium phosphate (32P)","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:04:23.519016+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107525/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:04:25.397006+00:00"}},"allNames":"phosphotope","offLabel":[],"synonyms":["sodium phosphate (32P)","disodium hydrogen phosphate (32P)","sodium phosphate P-32","sodium phosphate P 32","phosphotope"],"timeline":[{"date":"1959-03-04","type":"positive","source":"DrugCentral","milestone":"FDA approval (Mallinckrodt)"}],"approvals":[{"date":"1959-03-04","orphan":false,"company":"MALLINCKRODT","regulator":"FDA"}],"brandName":"Phosphotope","ecosystem":[{"indication":"Polycythemia vera","otherDrugs":[{"name":"mechlorethamine","slug":"mechlorethamine","company":"Recordati Rare"},{"name":"ropeginterferon alfa-2b","slug":"ropeginterferon-alfa-2b","company":"Pharma Essentia Corporation"},{"name":"ruxolitinib","slug":"ruxolitinib","company":"Incyte Corp"},{"name":"uracil mustard","slug":"uracil-mustard","company":""}],"globalPrevalence":2400000}],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Phosphotope's mechanism of action involves the emission of beta particles, which interact with the DNA of bone marrow cells, leading to cell death and a subsequent reduction in red blood cell production."},"commercial":{"launchDate":"1959","_launchSource":"DrugCentral (FDA 1959-03-04, MALLINCKRODT)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5036","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=sodium phosphate (32P)","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:39:24.305085","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:04:27.200686+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ibritumomab tiuxetan","drugSlug":"ibritumomab-tiuxetan","fdaApproval":"2002-02-19","relationship":"same-class"},{"drugName":"radium Ra 223 dichloride","drugSlug":"radium-ra-223-dichloride","fdaApproval":"2013-05-15","relationship":"same-class"},{"drugName":"lutetium (177Lu) oxodotreotide","drugSlug":"lutetium-(177lu)-oxodotreotide","fdaApproval":"2018-01-26","relationship":"same-class"},{"drugName":"lutetium (177Lu) vipivotide tetraxetan","drugSlug":"lutetium-(177lu)-vipivotide-tetraxetan","fdaApproval":"2022-03-23","relationship":"same-class"}],"genericName":"sodium phosphate (32p)","indications":{"approved":[{"name":"Polycythemia vera","source":"DrugCentral","snomedId":109992005,"regulator":"FDA","usPrevalence":null,"globalPrevalence":2400000,"prevalenceMethod":"curated","prevalenceSource":"Orphanet ([EXPERT]_European Medicines Agency 2014[INST])"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ibritumomab-tiuxetan","brandName":"ibritumomab tiuxetan","genericName":"ibritumomab tiuxetan","approvalYear":"2002","relationship":"same-class"},{"drugId":"radium-ra-223-dichloride","brandName":"radium Ra 223 dichloride","genericName":"radium Ra 223 dichloride","approvalYear":"2013","relationship":"same-class"},{"drugId":"lutetium-(177lu)-oxodotreotide","brandName":"lutetium (177Lu) oxodotreotide","genericName":"lutetium (177Lu) oxodotreotide","approvalYear":"2018","relationship":"same-class"},{"drugId":"lutetium-(177lu)-vipivotide-tetraxetan","brandName":"lutetium (177Lu) vipivotide tetraxetan","genericName":"lutetium (177Lu) vipivotide tetraxetan","approvalYear":"2022","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000146520","MMSL":"d04529","NDDF":"009990","UNII":"O181101B5G","VUID":"4018186","VANDF":"4018186","INN_ID":"527","RXNORM":"91559","UMLSCUI":"C0305007","chemblId":"CHEMBL2107525","ChEMBL_ID":"CHEMBL2107525","DRUGBANK_ID":"DB09370","PUBCHEM_CID":"71180"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1959-","companyName":"Mallinckrodt","relationship":"Original Developer"}],"publicationCount":1,"therapeuticAreas":["Hematology"],"atcClassification":{"source":"DrugCentral","atcCode":"V10XX01","allCodes":["V10XX01"]},"biosimilarFilings":[],"originalDeveloper":"Mallinckrodt","recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Mallinckrodt","companyId":"mallinckrodt","modality":"Small Molecule","firstApprovalDate":"1959","aiSummary":"Phosphotope is a small molecule radiopharmaceutical. It is also known by other names, including 32P, Sodium Phosphate (32P), and Sodium Phosphorus (32P) Phosphate.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1957-05-02T00:00:00.000Z","mah":"BRACCO","brand_name_local":"PHOSPHOTOPE","application_number":"NDA010927"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1959-03-04T00:00:00.000Z","mah":"MALLINCKRODT","brand_name_local":null,"application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:04:27.200686+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}